Stock TTKHLTCARE TTK HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials TTK Healthcare Limited

Equities

TTKHLTCARE

INE910C01018

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
1,588 INR -1.13% Intraday chart for TTK Healthcare Limited +5.14% +12.65%
Feb. 02 TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024 CI
Feb. 02 TTK Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Capitalization 1 14,869 9,590 4,620 6,989 11,715 14,611
Enterprise Value (EV) 1 14,341 8,638 3,614 4,910 9,208 6,417
P/E ratio 81.9 x 39.3 x 37.5 x 15 x 28.2 x 2.28 x
Yield 0.48% 0.74% 0.92% 1.21% 1.21% 0.97%
Capitalization / Revenue 2.57 x 1.53 x 0.72 x 1.1 x 1.96 x 2.01 x
EV / Revenue 2.48 x 1.38 x 0.56 x 0.77 x 1.54 x 0.89 x
EV / EBITDA 33.7 x 17.2 x 12.8 x 14.3 x 42.2 x 20.4 x
EV / FCF -67.8 x 18.7 x 89.8 x 6.89 x 82.9 x -13 x
FCF Yield -1.47% 5.34% 1.11% 14.5% 1.21% -7.69%
Price to Book 6.38 x 3.81 x 1.86 x 2.37 x 3.55 x 1.53 x
Nbr of stocks (in thousands) 14,130 14,130 14,130 14,130 14,130 14,130
Reference price 2 1,052 678.6 327.0 494.6 829.1 1,034
Announcement Date 7/13/18 7/15/19 8/18/20 7/23/21 7/6/22 6/28/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 5,775 6,279 6,458 6,365 5,992 7,251
EBITDA 1 425.8 501.9 282.5 343.2 218 314.4
EBIT 1 274.2 358.7 145.1 213.1 92.82 186.8
Operating Margin 4.75% 5.71% 2.25% 3.35% 1.55% 2.58%
Earnings before Tax (EBT) 1 301.5 392.6 194.2 370.5 248.4 616.4
Net income 1 181.7 243.7 123.2 464.4 415.9 6,397
Net margin 3.15% 3.88% 1.91% 7.3% 6.94% 88.22%
EPS 2 12.86 17.25 8.719 32.87 29.43 452.7
Free Cash Flow 1 -211.4 461.3 40.25 712.7 111 -493.7
FCF margin -3.66% 7.35% 0.62% 11.2% 1.85% -6.81%
FCF Conversion (EBITDA) - 91.91% 14.25% 207.67% 50.94% -
FCF Conversion (Net income) - 189.27% 32.68% 153.47% 26.7% -
Dividend per Share 2 5.000 5.000 3.000 6.000 10.00 10.00
Announcement Date 7/13/18 7/15/19 8/18/20 7/23/21 7/6/22 6/28/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 529 951 1,006 2,079 2,508 8,193
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -211 461 40.3 713 111 -494
ROE (net income / shareholders' equity) 9.3% 10.1% 4.92% 17.1% 5.93% 6.96%
ROA (Net income/ Total Assets) 4.95% 5.45% 2.14% 2.88% 1.1% 1.35%
Assets 1 3,669 4,474 5,752 16,133 37,739 473,581
Book Value Per Share 2 165.0 178.0 176.0 209.0 233.0 675.0
Cash Flow per Share 2 10.60 7.890 5.330 6.760 10.50 6.600
Capex 1 44.3 43.3 122 17.3 64.9 117
Capex / Sales 0.77% 0.69% 1.89% 0.27% 1.08% 1.61%
Announcement Date 7/13/18 7/15/19 8/18/20 7/23/21 7/6/22 6/28/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
TTK HEALTHCARE LIMITED Stock TTK Healthcare Limited
+12.65% 269M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-3.38% 3.93B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. TTKHLTCARE Stock
  4. Financials TTK Healthcare Limited